Active · per the CBE, 29 September 2026

BELGOPHARMA

BE0762935682

Rechtspersoon Private limited company 1 establishment

BELGOPHARMA is a wholesaler in Anderlecht. Private Limited, started on 4 February 2021, 1 establishment.

Bergense Steenweg 1160, 1070 Anderlecht

Active for

5 year, 7 months

Financials

Financial year 2025

BELGOPHARMA from Anderlecht, company number BE0762935682, closed financial year 2025 with a result of € 412,067 after tax. For that financial year BELGOPHARMA recorded a gross margin of € 754,756 and equity of € 2.7 million. Compared with financial year 2024, the result moved from € 1.2 million to € 412,067. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 2.7 million

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 412,067

▼ 67% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.3 million

▼ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 2.7 million.

People and assets in 2025

Vehicles and equipment

€ 12,344

▲ 227% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 548,770

▲ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 401,998

▼ 25% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Revenue € 3,845,525 - - -
Gross margin € 583,644 € 885,204 € 1,768,278 € 754,756 ▼ 57%
Profit after taxes € 412,578 € 586,699 € 1,235,354 € 412,067 ▼ 67%
Equity € 440,520 € 1,027,219 € 2,262,574 € 2,674,640 ▲ 18%
Total debts € 1,263,341 € 925,771 € 1,053,696 € 957,585 ▼ 9%
Cash € 441,880 € 762,599 € 1,920,722 € 1,328,708 ▼ 31%
Retained profit € 434,320 € 1,021,019 € 2,256,374 € 2,668,440 ▲ 18%
Balance sheet total € 1,703,861 € 1,952,990 € 3,316,269 € 3,632,225 ▲ 10%

Key figures of BELGOPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BELGOPHARMA?

What happened at BELGOPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 412,067 (▼ 67% vs 2024). Source: NBB ↗
  • New establishment in Anderlecht. KBO
  • Start of the company according to the CBE. KBO

In short

From € 412,578 profit in 2022 to € 412,067 profit in 2025.

Paid € 1.2 million in corporate taxes since 2022.

Best year ever: 2024, with € 1.2 million profit.

Original PDFs at the National Bank ↗

A new publication or filing at BELGOPHARMA? We notify you, reason included.

Follow BELGOPHARMA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

  1. Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
  2. We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
  3. In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Yes, I want that
See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies
  • De Lijn 8 June 2026 New annual account 2025

    filed on 8 June 2026

    What was left

    € 20 k ▼ 91%

    Money in the bank

    € 178 k ▼ 98%

    Open the dossier →

  • NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
  • bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Bergense Steenweg 1160

1070 Anderlecht

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

DASD Construct

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0762.935.682
VAT number
BE 0762.935.682
Registered office
Bergense Steenweg 1160, 1070 Anderlecht
Names & denominations
BELGOPHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 February 2021
Peppol
Active · Active since 4 Dec 2025
Activities · NACE

Groothandel in farmaceutische en medische artikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What does BELGOPHARMA do?
BELGOPHARMA is a wholesaler in Anderlecht. Private Limited, started on 4 February 2021, 1 establishment.
What is the address of BELGOPHARMA?
The registered office of BELGOPHARMA is located at Bergense Steenweg 1160, 1070 Anderlecht.
Is BELGOPHARMA still active?
Yes. According to the CBE (29 September 2026) BELGOPHARMA is active, legal situation “Normale toestand”, started on 4 February 2021.
Is BELGOPHARMA registered on Peppol?
Yes, BELGOPHARMA is registered on the Peppol network with ID 0208:0762935682.
What is the enterprise number of BELGOPHARMA?
The enterprise number of BELGOPHARMA is BE0762935682.
When was BELGOPHARMA founded?
BELGOPHARMA was founded on 4 February 2021.